Herein, we discuss key inflammatory signaling pathways, with more focus on the TLRs- NF-ĸB/IFN and associated pathways and the possibility of targeting these pathways as a therapeutic strategy that could indiscriminately benefit HIV- and non-HIV-infected CRC patients. The gene discussed is IFNA1; the disease is colorectal carcinoma.